De Luca Pietro, Di Stadio Arianna, de Campora Luca, De Bonis Egidio, Fermi Matteo, Petruzzi Gerardo, Atturo Francesca, Colangeli Roberta, Scarpa Alfonso, Lo Manto Alfredo, Colizza Andrea, Cintoli Giulia, Togo Giulia, Salzano Giovanni, Crescenzi Domenico, Ralli Massimo, Abbate Vincenzo, Ricciardiello Filippo, Magaldi Luciano, D'Ecclesia Aurelio, di Massa Gianluca, Costarelli Leopoldo, Merenda Elisabetta, Corsi Alessandro, Covello Renato, Di Crescenzo Rosa Maria, Duda Loren, Dimitri Lucia Maria, Caputo Alessandro, Ferrara Gerardo, Lucante Teresina, Longo Francesco, Tassone Domenico, Iemma Maurizio, Cassano Michele, Salzano Francesco Antonio, Califano Luigi, Marchioni Daniele, Pellini Raul, de Vincentiis Marco, Presutti Livio, Ionna Franco, de Campora Enrico, Radici Marco, Camaioni Angelo
Otolaryngology Department, Fatebenefratelli Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.
Otolaryngology Unit, University of Catania, 95131 Catania, Italy.
Cancers (Basel). 2023 Nov 17;15(22):5456. doi: 10.3390/cancers15225456.
The acinic cell carcinoma (AciCC) of the parotid gland is a rare tumor with an indolent behavior; however, a subgroup of this tumor presents an aggressive behavior with a tendency to recur. The aim of this multicenter study was to identify and stratify those patients with AciCC at high risk of tumor recurrence.
A retrospective study was carried out involving 77 patients treated with surgery between January 2000 and September 2022, in different Italian referral centers. Data about tumor characteristics and its recurrence were collected. The histological specimens and slides were independently reviewed by a senior pathologist coordinator (L.C.) and the institution's local head and neck pathologist.
The patients' age average was 53.6 years, with a female prevalence in the group. The mean follow-up was 67.4 months (1-258, SD 59.39). The five-year overall survival (OS) was 83.2%. The 5-year disease-free survival (DFS) was 60% (95% CI 58.2-61.7). A high incidence of necrosis, extraglandular spread, lymphovascular invasion (LVI), atypical mitosis, and cellular pleomorphism was observed in the high-risk tumors compared to the low-risk ones.
AciCC generally had an indolent behavior, optimal OS, DFS with few cervical node metastases, and rare distant relapses. This multicenter retrospective case series provides evidence of the need for clinical-epidemiological-histological stratification for patients at risk of poor outcomes. Our results suggest that the correct definition of high-risk AciCC should include tumor size, the presence of necrosis, extraglandular spread, LVI, atypical mitosis, and cellular pleomorphism.
腮腺腺泡细胞癌(AciCC)是一种罕见肿瘤,生物学行为惰性;然而,该肿瘤的一个亚组具有侵袭性,有复发倾向。这项多中心研究的目的是识别并分层那些有肿瘤复发高风险的AciCC患者。
开展一项回顾性研究,纳入2000年1月至2022年9月期间在意大利不同转诊中心接受手术治疗的77例患者。收集有关肿瘤特征及其复发的数据。组织学标本和玻片由一位资深病理科协调员(L.C.)以及该机构的当地头颈病理科主任独立复查。
患者平均年龄为53.6岁,该组中女性居多。平均随访时间为67.4个月(1 - 258,标准差59.39)。五年总生存率(OS)为83.2%。五年无病生存率(DFS)为60%(95%置信区间58.2 - 61.7)。与低风险肿瘤相比,高风险肿瘤中坏死、腺外扩散、脉管侵犯(LVI)、非典型有丝分裂和细胞多形性的发生率较高。
AciCC通常生物学行为惰性,总生存率和无病生存率良好,颈部淋巴结转移少,远处复发罕见。这个多中心回顾性病例系列证明了对预后不良风险患者进行临床 - 流行病学 - 组织学分层的必要性。我们的结果表明,高危AciCC的正确定义应包括肿瘤大小、坏死的存在、腺外扩散、LVI、非典型有丝分裂和细胞多形性。